These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 19443197)

  • 1. Diet and the role of 11beta-hydroxysteroid dehydrogenase-1 on obesity.
    London E; Castonguay TW
    J Nutr Biochem; 2009 Jul; 20(7):485-93. PubMed ID: 19443197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
    Stimson RH; Walker BR
    Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease.
    Morton NM
    Mol Cell Endocrinol; 2010 Mar; 316(2):154-64. PubMed ID: 19804814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action.
    Draper N; Stewart PM
    J Endocrinol; 2005 Aug; 186(2):251-71. PubMed ID: 16079253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11beta-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory.
    Seckl JR; Walker BR
    Trends Endocrinol Metab; 2004 Nov; 15(9):418-24. PubMed ID: 15519888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11Beta-hydroxysteroid dehydrogenase type 1 in human disease: a novel therapeutic target.
    Tomlinson JW
    Minerva Endocrinol; 2005 Mar; 30(1):37-46. PubMed ID: 15877012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease.
    Walker BR; Andrew R
    Ann N Y Acad Sci; 2006 Nov; 1083():165-84. PubMed ID: 17148739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus.
    Pereira CD; Azevedo I; Monteiro R; Martins MJ
    Diabetes Obes Metab; 2012 Oct; 14(10):869-81. PubMed ID: 22321826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid exposure and tissue gene expression of 11beta HSD-1, 11beta HSD-2, and glucocorticoid receptor in a porcine model of differential fetal growth.
    McNeil CJ; Nwagwu MO; Finch AM; Page KR; Thain A; McArdle HJ; Ashworth CJ
    Reproduction; 2007 Mar; 133(3):653-61. PubMed ID: 17379659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target.
    Wamil M; Seckl JR
    Drug Discov Today; 2007 Jul; 12(13-14):504-20. PubMed ID: 17631244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and activity of 11beta-hydroxysteroid dehydrogenase type 1 enzyme in subcutaneous and visceral adipose tissue of prepubertal children.
    Mericq V; Medina P; Bouwman C; Johnson MC; Godoy J; López T; Iñiguez G
    Horm Res; 2009; 71(2):89-93. PubMed ID: 19129713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic regulation of adiposity: the role of 11beta-hydroxysteroid dehydrogenase type 1.
    Hochberg Z; Friedberg M; Yaniv L; Bader T; Tiosano D
    Horm Metab Res; 2004 Jun; 36(6):365-9. PubMed ID: 15241725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors for metabolic syndrome.
    Schnackenberg CG
    Curr Opin Investig Drugs; 2008 Mar; 9(3):295-300. PubMed ID: 18311666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
    Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K
    Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of adipose 11beta-hydroxysteroid dehydrogenase type 1 by high-fat feeding in mice: a potential adaptive mechanism counteracting metabolic disease.
    Morton NM; Ramage L; Seckl JR
    Endocrinology; 2004 Jun; 145(6):2707-12. PubMed ID: 15044372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A transgenic model of visceral obesity and the metabolic syndrome.
    Masuzaki H; Paterson J; Shinyama H; Morton NM; Mullins JJ; Seckl JR; Flier JS
    Science; 2001 Dec; 294(5549):2166-70. PubMed ID: 11739957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High fructose diets increase 11β-hydroxysteroid dehydrogenase type 1 in liver and visceral adipose in rats within 24-h exposure.
    London E; Castonguay TW
    Obesity (Silver Spring); 2011 May; 19(5):925-32. PubMed ID: 21127473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response.
    Chapman KE; Coutinho A; Gray M; Gilmour JS; Savill JS; Seckl JR
    Ann N Y Acad Sci; 2006 Nov; 1088():265-73. PubMed ID: 17192572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen.
    Paulsen SK; Nielsen MP; Richelsen B; Bruun JM; Flyvbjerg A; Pedersen SB
    Obesity (Silver Spring); 2008 Apr; 16(4):731-5. PubMed ID: 18379559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
    Wake DJ; Walker BR
    Mol Cell Endocrinol; 2004 Feb; 215(1-2):45-54. PubMed ID: 15026174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.